Specifically, CREMa increases IL-17A transcription (33) and the transcription factor RFX1 regulates the expression of CD11a and CD70 (34) through histone modifications in lupus CD4+ T cells. This evidence concerns the gene IL17A and systemic lupus erythematosus.